Why GANX? Gain Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
GANX
$1.91+0.04 (+2.14%)
After Hours$1.91+0.00 (+0.00%)· Last close May 6
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.